Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal–Bolus Therapy

समान संसाधन

• A 1‐year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal–bolus insulin therapy (Kumamoto Insulin Degludec Observational study)
  द्वारा: Shimoda, Seiya, और अन्य
  प्रकाशित: (2016)
• Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study
  द्वारा: Tosaka, Yuka, और अन्य
  प्रकाशित: (2015)
• Switching to Degludec From Other Basal Insulins Is Associated With Reduced Hypoglycemia Rates: A Prospective Study
  द्वारा: Fadini, Gian Paolo, और अन्य
  प्रकाशित: (2019)
• Degludec insulin: A novel basal insulin
  द्वारा: Kalra, Sanjay, और अन्य
  प्रकाशित: (2011)
• Effect of switching basal insulin regimen to degludec on quality of life in Japanese patients with type 1 and type 2 diabetes mellitus
  द्वारा: Okada, Morihiro, और अन्य
  प्रकाशित: (2015)